Endometrial Adenosquamous Carcinoma

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Active, not recruiting
  • Endometrial Adenocarcinoma
  • +9 more
  • Bevacizumab
  • +5 more
  • Phoenix, Arizona
  • +232 more
Jan 12, 2023

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in

Active, not recruiting
  • Endometrial Adenosquamous Carcinoma
  • +9 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +18 more
Oct 15, 2022

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
  • Endometrial Adenocarcinoma
  • +4 more
  • Akt Inhibitor MK2206
  • Laboratory Biomarker Analysis
  • Boston, Massachusetts
  • +6 more
Jan 13, 2022

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
  • Endometrial Adenocarcinoma
  • +3 more
  • Los Angeles, California
  • +71 more
Jul 19, 2019

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Canada, Hong

Completed
  • Endometrial Adenocarcinoma
  • +11 more
  • Bevacizumab
  • +4 more
  • Berkeley, California
  • +40 more
Feb 15, 2018

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma Trial in United

Completed
  • Endometrial Adenosquamous Carcinoma
  • +10 more
  • Hartford, Connecticut
  • +8 more
Aug 23, 2017

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous

Completed
  • Endometrial Adenocarcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Mar 17, 2016

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Philadelphia

Completed
  • Endometrial Adenocarcinoma
  • +5 more
  • Doxorubicin Hydrochloride
  • +4 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Apr 30, 2015